Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 337,729 |
|
|||||
| News | - | ||||||
| Day High | 29.59 | Low High |
|||||
| Day Low | 28.25 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Morphic Holding Inc | MORF | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.68 | 2.39% | 29.18 | 15:20:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 28.41 | 28.25 | 29.59 | 28.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,158 | 337,729 | $ 28.77 | $ 9,717,398 | - | 19.345 - 63.0825 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 15:20:32 | 10 | $ 29.16 | USD |
Morphic Holding Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.45B | 50.04M | - | 521k | -152.1M | -3.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Morphic News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MORF Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 29.18 | 29.635 | 27.12 | 27.94 | 401,252 | 0.00 | 0.00% |
| 1 Month | 32.70 | 35.56 | 27.12 | 30.30 | 396,810 | -3.52 | -10.76% |
| 3 Months | 31.84 | 41.47 | 27.12 | 34.50 | 495,696 | -2.66 | -8.35% |
| 6 Months | 20.32 | 41.47 | 19.345 | 29.61 | 533,050 | 8.86 | 43.60% |
| 1 Year | 44.54 | 63.0825 | 19.345 | 35.88 | 687,577 | -15.36 | -34.49% |
| 3 Years | 56.40 | 68.75 | 19.23 | 36.73 | 412,296 | -27.22 | -48.26% |
| 5 Years | 18.00 | 93.00 | 9.90 | 37.90 | 305,163 | 11.18 | 62.11% |
Morphic Description
| Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. |
